Figure 1
From: Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Relationship between percent change in plasma PCSK9 and LDL-cholesterol levels following fibrate treatment. PCSK9 and LDL-C were measured pre- and post-fibrate therapy as described in Methods. Pre-treatment levels were set as 100%.